Cargando…
Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach
OBJECTIVE: Spasmolytic polypeptide-expressing metaplasia (SPEM) is a regenerative lesion in the gastric mucosa and is a potential precursor to intestinal metaplasia/gastric adenocarcinoma in a chronic inflammatory setting. The goal of these studies was to define the transcriptional changes associate...
Autores principales: | Bockerstett, Kevin A, Lewis, Scott A, Wolf, Kyle J, Noto, Christine N, Jackson, Nicholas M, Ford, Eric L, Ahn, Tae-Hyuk, DiPaolo, Richard J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282188/ https://www.ncbi.nlm.nih.gov/pubmed/31481545 http://dx.doi.org/10.1136/gutjnl-2019-318930 |
Ejemplares similares
-
CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype
por: Barros, Rita, et al.
Publicado: (2010) -
Chief cell plasticity is the origin of metaplasia following acute injury in the stomach mucosa
por: Caldwell, Brianna, et al.
Publicado: (2022) -
DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia
por: Krishnan, Vaidehi, et al.
Publicado: (2020) -
Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication
por: Sung, Joseph J Y, et al.
Publicado: (2020) -
Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)
por: Lee, Jonathan W J, et al.
Publicado: (2022)